The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Dec. 24, 2024
Filed:
Oct. 25, 2018
Applicants:
Children's Medical Center Corporation, Boston, MA (US);
The Brigham & Women's Hospital, Inc., Boston, MA (US);
Inventors:
Assignees:
Children's Medical Center Corporation, Boston, MA (US);
Brigham & Women's Hospital, Inc., Boston, MA (US);
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/4706 (2006.01); A61K 31/341 (2006.01); A61K 31/353 (2006.01); A61K 31/381 (2006.01); A61K 31/4025 (2006.01); A61K 31/404 (2006.01); A61K 31/4162 (2006.01); A61K 31/4178 (2006.01); A61K 31/4188 (2006.01); A61K 31/422 (2006.01); A61K 31/4245 (2006.01); A61K 31/428 (2006.01); A61K 31/429 (2006.01); A61K 31/433 (2006.01); A61K 31/4365 (2006.01); A61K 31/437 (2006.01); A61K 31/4375 (2006.01); A61K 31/47 (2006.01); A61K 31/4709 (2006.01); A61K 31/472 (2006.01); A61K 31/473 (2006.01); A61K 31/4741 (2006.01); A61K 31/496 (2006.01); A61K 31/498 (2006.01); A61K 31/4985 (2006.01); A61K 31/499 (2006.01); A61K 31/502 (2006.01); A61K 31/5025 (2006.01); A61K 31/506 (2006.01); A61K 31/517 (2006.01); A61K 31/519 (2006.01); A61K 31/52 (2006.01); A61K 31/53 (2006.01); A61K 31/5377 (2006.01); A61K 31/538 (2006.01); A61K 31/5415 (2006.01); A61K 31/549 (2006.01); A61K 31/55 (2006.01); A61K 31/551 (2006.01); C12Q 1/66 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4706 (2013.01); A61K 31/341 (2013.01); A61K 31/353 (2013.01); A61K 31/381 (2013.01); A61K 31/4025 (2013.01); A61K 31/404 (2013.01); A61K 31/4162 (2013.01); A61K 31/4178 (2013.01); A61K 31/4188 (2013.01); A61K 31/422 (2013.01); A61K 31/4245 (2013.01); A61K 31/428 (2013.01); A61K 31/429 (2013.01); A61K 31/433 (2013.01); A61K 31/4365 (2013.01); A61K 31/437 (2013.01); A61K 31/4375 (2013.01); A61K 31/47 (2013.01); A61K 31/4709 (2013.01); A61K 31/472 (2013.01); A61K 31/473 (2013.01); A61K 31/4741 (2013.01); A61K 31/496 (2013.01); A61K 31/498 (2013.01); A61K 31/4985 (2013.01); A61K 31/499 (2013.01); A61K 31/502 (2013.01); A61K 31/5025 (2013.01); A61K 31/506 (2013.01); A61K 31/517 (2013.01); A61K 31/519 (2013.01); A61K 31/52 (2013.01); A61K 31/53 (2013.01); A61K 31/5377 (2013.01); A61K 31/538 (2013.01); A61K 31/5415 (2013.01); A61K 31/549 (2013.01); A61K 31/55 (2013.01); A61K 31/551 (2013.01); C12Q 1/66 (2013.01); G01N 2333/90241 (2013.01); G01N 2333/91245 (2013.01);
Abstract
The disclosure relates to compounds that are, e.g., PAP Associated Domain Containing 5 (PAPD5) inhibitors and methods of use thereof.